Jian Hou
- Hematology top 0.5%
- Multiple Myeloma Research and Treatments 92
- Oncology top 2%
- Peptidase Inhibition and Analysis 28
- Cancer Treatment and Pharmacology 13
- Chemokine receptors and signaling 11
- Immunology top 5%
- Immunotherapy and Immune Responses 11
- Immune Cell Function and Interaction 10
- Molecular Biology top 5%
- Protein Degradation and Inhibitors 39
- Ubiquitin and proteasome pathways 12
- Cancer Research top 10%
- Co-authors
- Weijun FuJuan DuQing YiHua JiangJahangir AbdiHejing HuangHui ZhangXiao‐Jun Huang
- Cited by
- HematologyOncologyImmunology
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Jian Hou
148 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 113
- Hematology 1.1k
- Oncology 1.1k
- Immunology 634
- Molecular Biology 1.7k
- Cancer Research 294
Countries citing papers authored by Jian Hou
This map shows the geographic impact of Jian Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jian Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jian Hou more than expected).
Fields of papers citing papers by Jian Hou
This network shows the impact of papers produced by Jian Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jian Hou. The network helps show where Jian Hou may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jian Hou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 26 | |
| 5 | 2024 | 2 | |
| 6 | 2023 | 9 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 16 | |
| 9 | 2023 | 9 | |
| 10 | 2023 | 13 | |
| 11 | 2023 | 77 | |
| 12 | 2015 | 8 | |
| 13 | 2015 | 8 | |
| 14 | 2013 | 22 | |
| 15 | 2012 | 132 | |
| 16 | Composite lymphoma on neck:a clinicopathological observation and literature review | 2011 | 1 |
| 17 | 2010 | 21 | |
| 18 | 2008 | 17 | |
| 19 | 2007 | 2 | |
| 20 | 2004 | 3 |
About Jian Hou
Jian Hou is a scholar working on Hematology, Oncology and Molecular Biology, having authored 154 papers that have together received 2.9k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (92 papers), Protein Degradation and Inhibitors (39 papers), Peptidase Inhibition and Analysis (28 papers), Cancer Treatment and Pharmacology (13 papers), Ubiquitin and proteasome pathways (12 papers), Immunotherapy and Immune Responses (11 papers), Chemokine receptors and signaling (11 papers) and Immune Cell Function and Interaction (10 papers). The work is most often cited by research in Hematology (1.1k citations), Oncology (1.1k citations) and Immunology (634 citations). Jian Hou has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Weijun Fu, Juan Du, Qing Yi, Hua Jiang, Jahangir Abdi, Hejing Huang, Hui Zhang, Xiao‐Jun Huang, Hernán E. Grecco and Tianmei Zeng. Their work appears in journals such as Blood, Leukemia Research, Journal of Hematology & Oncology, Oncotarget and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.